Focus Partners Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122M Sell
360,036
-6,319
-2% -$2.25M 0.14% 158
2025
Q4
$114M Buy
366,355
+138,334
+61% +$43.9M 0.13% 159
2025
Q3
$64.3M Buy
228,021
+8,839
+4% +$2.56M 0.1% 171
2025
Q2
$61.2M Sell
219,182
-2,306
-1% -$653K 0.13% 158
2025
Q1
$69M Buy
221,488
+30,201
+16% +$8.92M 0.17% 128
2024
Q4
$49.9M Buy
191,287
+94,403
+97% +$28M 0.13% 162
2024
Q3
$31.2M Sell
96,884
-16,646
-15% -$5.45M 0.1% 201
2024
Q2
$35.5M Buy
113,530
+7,852
+7% +$2.31M 0.12% 169
2024
Q1
$30M Buy
105,678
+78,274
+286% +$22.9M 0.24% 106
2023
Q4
$7.89M Buy
+27,404
New +$7.47M 0.1% 176

Other funds holding AMGN

Focus Partners Wealth's AMGN Position: Q1 2026 in Review

Focus Partners Wealth reduced its Amgen (AMGN) stake by 1.7% in Q1 2026, selling an estimated $2.25M and leaving 360,036 shares worth $122M. The position accounts for 0.14% of the portfolio, ranked #158.

Focus Partners Wealth first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Focus Partners Wealth held 360,036 shares of Amgen worth $122M as of Q1 2026.
  • Focus Partners Wealth sold 6,319 Amgen shares in Q1 2026, an estimated $2.25M.
  • Amgen made up 0.14% of Focus Partners Wealth's portfolio in Q1 2026, its #158 holding.
  • Focus Partners Wealth first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.